文献速递生殖医学

拮抗剂方案辅助生殖技术周期中促性腺激素释放激素类似物作为唯一黄体支持

Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles.
PubMed 文献 · Fertil Steril · 2016-10-27

这项回顾性队列研究在私立生殖诊所分析了2009至2015年间1479名女性的2529个拮抗剂方案IVF周期,比较鼻喷GnRH激动剂与阴道黄体酮作为唯一黄体支持的活产率。结果显示GnRH激动剂组活产率显著高于黄体酮组,校正年龄、BMI等因素后GnRH激动剂仍与较高活产率相关(OR 1.46,95%CI 1.10-1.94)。

要点

  • 拮抗剂方案中鼻喷GnRH激动剂作为唯一黄体支持与较高活产率相关。
  • 校正年龄、BMI、既往产科史、IVF周期数、获卵数和移植胚胎数后OR为1.46(95%CI 1.10-1.94)。
  • 获得阳性β-hCG后,两组化学妊娠率和流产率无统计学差异。

核心结论

  • 这项大型回顾性研究提示,重复鼻喷GnRH激动剂用于黄体支持与较高活产率相关,优于标准黄体酮补充。

研究设计与样本

  • 回顾性队列研究,在私立生殖诊所进行,纳入2009至2015年间在该诊所完成的拮抗剂方案周期。
  • 共分析1479名女性的2529个拮抗剂方案周期,其中GnRH激动剂组1436个周期(56.7%),黄体酮补充组1093个周期(43.2%)。

主要发现

  • 整个GnRH激动剂组活产率显著高于黄体酮组。
  • 在年龄大于35岁的女性中单独分析时,该结果更为突出。
  • 校正年龄、体重指数(BMI)、既往产科史、IVF周期数、获卵数和移植胚胎数后,GnRH激动剂仍与较高活产率相关(OR 1.46,95%CI 1.10-1.94)。
  • 获得阳性β-hCG后,GnRH激动剂组与黄体酮补充组的化学妊娠率和流产率无统计学差异,GnRH激动剂与较高活产率相关(OR 1.59,95%CI 1.07-2.36)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the efficacy of GnRH agonists (GnRH-a) as sole luteal phase support in patients undergoing IVF in antagonist-based cycles compared with standard vaginal P preparations. DESIGN: Retrospective cohort. SETTING: Private fertility clinic. PATIENT(S): Patients who underwent antagonist-based cycles performed at our clinic between 2009 and 2015. INTERVENTION(S): Intranasal GnRH-a or vaginal P as luteal support. MAIN OUTCOME MEASURE(S): Live birth rates. RESULT(S): A total of 2,529 antagonist-based cycles from 1,479 women were available for analysis, in which GnRH-a were used in 1,436 cycles (56.7%) and P supplementation in 1,093 cycles (43.2%). Significantly higher live birth rates were demonstrated for the entire GnRH-a group compared with the P group. This result was even more prominent when women older than 35 years were considered separately. Furthermore, after adjustment for age, body mass index (BMI), past obstetric history, number of IVF cycles, oocyte retrieved and embryos transferred, GnRH-a was still associated with a higher rate of live birth (odds ratio 1.46, 95% confidence interval 1.10-1.94). Once a positive β-hCG was achieved, chemical pregnancy rates (PRs) and miscarriage rates were not statistically different between the GnRH-a and the P supplementation group, and GnRH-a was associated with a higher rate of live births (odds ratio 1.59, 95% confidence interval 1.07-2.36). CONCLUSION(S): This large retrospective study suggests that repeated intranasal GnRH-a for luteal phase support is associated with a higher live birth rate compared with standard P supplementations.

来源:Fertil Steril,查看原文。版权归原作者所有。

引用

  1. Bar Hava I, Blueshtein M, Ganer Herman H, et al. Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles. Fertil Steril. 2016. PMID: 28228316. doi:10.1016/j.fertnstert.2016.10.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。